ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO119

Protective Effects of Pemafibrate against Ischemia-Reperfusion-Induced AKI in Mice

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Nakayama, Yuki, Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Nimura, Takayuki, Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Yamaka, Kosuke, Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Aomura, Daiki, Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Hashimoto, Koji, Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Kamijo, Yuji, Shinshu Daigaku, Matsumoto, Nagano, Japan
Background

The effect of peroxisome proliferator-activated receptor alpha (PPARα) on acute kidney injury (AKI) is unknown due to the limited literature investigating the renoprotective effect of PPARα in AKI using fenofibrate. Pemafibrate, a novel PPARα modulator, is characterized by high selectivity for PPARα. In this study, we aimed to explore the function of PPARα using pemafibrate in renal ischemic injury.

Methods

Twelve-week-old male C57BL/6J mice were divided into two groups: the pemafibrate group, which received mixed pemafibrate in their diet for 1 week before surgery, and the normal diet group. Bilateral 35-minute ischemia-reperfusion (I/R) was performed on the mice to produce an ischemic AKI model (n=9 in both groups). A sham operation was also performed for control (n=3 in each group). All mice were sacrificed 24 hours after I/R or sham operation. Renal function, histology, and tissue gene expression were evaluated.

Results

Serum creatinine levels were significantly lower in the pemafibrate group than in the normal diet group. Pathological findings showed mild expansion of the urinary tubule lumen and slight loss of the brush border in the pemafibrate group compared to the normal diet group. RNA analyses revealed decreased expressions of urinary tubule injury markers and inflammatory genes. The renal PPARα expression was not significantly different between groups. However, oil red O staining showed less fat droplet accumulation, and the gene expressions of enzymes involved in fatty acid oxidation and anti-oxidative stress, which are target genes of PPARα, were up-regulated in the pemafibrate group.

Conclusion

Pemafibrate treatment attenuated ischemic AKI by activating fatty acid metabolism and reducing oxidative stress.